Company: RGNT
Filing Date: 2025-05-19
Form Type: F-1/A
Source: 0001213900-25-045479
Chunk: 232

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-19
Form: F-1/A
Chunk 232
---
 other than underwriting commissions incurred and payable by the
holders. The exercise price and number of shares issuable upon exercise of the Representative’s Warrants may be adjusted in certain
circumstances including in the event of a stock dividend or our recapitalization, reorganization, merger, or consolidation. However, neither
the Representative Warrant exercise price, nor the number of Ordinary Shares underlying such warrants, will be adjusted for issuances
of Ordinary Shares by us at a price below the exercise price of the Representative’s Warrants.

Discretionary Accounts

The underwriters do not intend
to confirm sales of the securities offered hereby to any accounts over which they have discretionary authority.

Lock-Up Agreements

Pursuant to certain “lock-up”
agreements, we, our executive officers and directors and current holders of our securities, have agreed, for a period of twelve (12) months
from the closing of this offering, with respect to our directors and executive officers and for a period of six (6) months from the closing
of this offering with respect to the Company and all other holders of our securities, not to (a) offer, pledge, sell, contract to sell,
sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend,
or otherwise transfer or dispose of, directly or indirectly, any shares of our capital stock or any securities convertible into or exercisable
or exchangeable for shares of our capital stock; (b) file or caused to be filed any registration statement with the Commission relating
to the offering of any shares of our capital stock or any securities convertible into or exercisable or exchangeable for shares of our
capital stock; (c) complete any offering of our debt securities, other than entering into a line of credit with a traditional bank or
(d) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of our capital stock, whether any such transaction described in clause (a), (b), (c) or (d) above is to be settled by delivery of shares
of our capital stock or such other securities, in cash or otherwise. We agree to file a customary universal shelf registration statement
within 30 days of the earlier of (i) the expiration of the restricted period described above and (ii) the date of its initial eligibility
to do so. Additionally, we agree that for a period of 24 months after